 |
Latest News |
| 14th October 2009 |
| |
Critical Pharmaceuticals Secures £1.5m From Wellcome Trust To Develop hGH Nasal Spray
|
|
| 27th January 2009 |
| |
Global Health Ventures and Critical Sign Memorandum of Understanding for an Anti-Obesity Drug
|
|
| 10th November 2008 |
| |
Critical Pharmaceuticals Raise £650K
|
|
| 1st October 2008 |
| |
Critical Pharmaceuticals Enter Sustained Release hGH Arena
|
|
|
Technology |
| |
Critical Pharmaceuticals uses its supercritical fluid technologies to encapsulate drugs within biodegradable polymers for controlled release applications. In a low temperature, single step, solvent free process we can make injectable microparticles, implants and fibrous materials that constantly release the drug over weeks to months.
|
| |
 |
| |
|
|
 |
| Event |
Date / Location |
Attendees |
|
BioTrinity
|
12-14 Apr 2010 Newbury, UK
|
Dr Gareth King, Chief Business Officer
www.biotrinity.com
|
|
Nasal Drug Delivery
|
14-15 Apr 2010 London, UK
|
Prof Lisbeth Illum, Chief Executive Officer
www.management-forum.co.uk
|
|
SMi Controlled Release
|
28-29 Apr 2010 London, UK
|
Dr Andy Lewis, Director Operations
www.smi-online.co.uk
|
|
BIO Convention
|
3-6 May 2010 Chicago, USA
|
Dr Gareth King, Chief Business Officer
convention.bio.org
|
| European Partnering and Investment Conference (EPIC) |
23 June 2010 London, UK |
Dr Gareth King, Chief Business Officer
www.epicbiotech.com
|
|
Controlled Release Society
|
10-14 July 2010 Portland, USA
|
Prof Lisbeth Illum, Chief Executive Officer
www.controlledrelease.org
|
|
AAPS Annual Meeting
|
14-18 Nov 2010 New Orleans, USA
|
Prof Lisbeth Illum, Chief Executive Officer
www.aapspharmaceutica.com
|
|
|
|
